Skip to content
glecaprevir

Structure via PubChem · Public domain (PubChem)

EntityQ28868720· pop 8· linked from 104 articles

glecaprevir

Sign in to save

Glecaprevir (INN,) is a hepatitis C virus (HCV) nonstructural (NS) protein 3/4A protease inhibitor that was identified jointly by AbbVie and Enanta Pharmaceuticals. It is being developed as a treatment of chronic hepatitis C infection in co-formulation with an HCV NS5A inhibitor pibrentasvir. Together they demonstrated potent antiviral activity against major HCV genotypes and high barriers to resistance in vitro.

Chemical data

Formula
C38H46F4N6O9S
Molecular weight
838.9 g/mol
IUPAC name
(1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide
SMILES
CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C
InChIKey
MLSQGNCUYAMAHD-ITNVBOSISA-N
XLogP
4.6
Polar surface area
204 Ų
H-bond donors
3
H-bond acceptors
15
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2017
Admin. routes
oral
Indications
liver disease, hepatitis C virus infection, chronic hepatitis C virus infection, kidney disease

via ChEMBL · EBI

Wikidata facts

Mass
838.9
Has use
medication
Show 1 more fact
chemical formula
C₃₈H₄₆F₄N₆O₉S
Sources (1)

via Wikidata · CC0

~3 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

{{Drugbox | IUPAC_name = (3aR,7S,10S,12R,21E,24aR)-7-tert-Butyl-N-{(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropane-1-sulfonyl)carbamoyl]cyclopropyl}-20,20-difluoro-5,8-dioxo-2,3,3a,5,6,7,8,11,12,20,23,24a-dodecahydro-1H,10H-9,12-methanocyclopenta[18,19][1,10,17,3,6]trioxadiazacyclonon adecino[11,12-b]quinoxaline-10-carboxamide | image = Glecaprevir.svg | image_class = skin-invert-image | width =

| tradename = Mavyret (combination with pibrentasvir) | Drugs.com = | licence_US = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = By mouth

Excerpted from Wikipedia’s “glecaprevir” article, available under the CC BY-SA 4.0 licence.

Available in 8 languages

via Wikidata sitelinks · CC0